Comparison of Safety and Immunogenicity of PVRV and PCECV Immunized in Patients with WHO Category II Animal Exposure: A Study Based on Different Age Groups

Open Access

Peer-reviewed

Research Article

Yuan Fang ,

Contributed equally to this work with: Yuan Fang, Li Chen

Affiliation Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⨯
Li Chen ,

Contributed equally to this work with: Yuan Fang, Li Chen

Affiliation Jianghan District Centers for Disease Control and Prevention, Wuhan, China
⨯
Man-Qing Liu,

Affiliation Wuhan Centers for Disease Control and Prevention, Wuhan, China
⨯
Zheng-Gang Zhu,

Affiliation Wuhan Centers for Disease Control and Prevention, Wuhan, China
⨯
Ze-Rong Zhu,

Affiliation Wuhan Centers for Disease Control and Prevention, Wuhan, China
⨯
Quan Hu

* E-mail: powerhu21@yahoo.com

Affiliation Wuhan Centers for Disease Control and Prevention, Wuhan, China
⨯

Reader Comments (0)

Age groups
Is the Subject Area "Age groups" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Rabies
Is the Subject Area "Rabies" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Fevers
Is the Subject Area "Fevers" applicable to this article?

Thanks for your feedback.
Rabies virus
Is the Subject Area "Rabies virus" applicable to this article?

Thanks for your feedback.